Deal profile | Gadens advises 4DMedical on successful acquisition of US medtech company, Imbio and its accompanying institutional placement

Gadens has advised 4DMedical Limited (4DMedical) on the acquisition US based Imbio Inc. Imbio is a recognised leader in lung and heart artificial intelligence (AI) driven technology and medical imaging. Imbio expands 4DMedical’s product offering by incorporating Imbio’s highly complementary suite of diagnostic products to help clinicians around the globe detect disease earlier, and make […]

Readmore

---

Deal profile | Gadens advises 4DMedical on successful ASX listing

Gadens has advised 4DMedical Limited on its A$55.79 million IPO and its successful listing on the Australian Securities Exchange.

Readmore

---